@FierceMedDev: Report: Insurers could gain up to $1B in J&J hip settlement deal. Item | Follow @FierceMedDev
@MarkHFierce: LabCorp has become the latest to roll out new BRCA tests - wondering when Myriad will sue them, too. Release | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Study: Natural nanomaterials could support biodegradable drug delivery. Story | Follow @MichaelGFierce
@GalenMoore: Infectious-disease biotech Visterra has raised $8.1M and licensed dengue-fever IP from its co-founder's lab at MIT. More | Follow @GalenMoore
> Sony ($SNE) is seeking a U.S. patent for "SmartWig" hairpieces that could, in part, check blood pressure. Story
> A special type of magnetic resonance imaging shows long-term brain differences in soldiers who suffered mild traumatic brain injury from mortar fire or other explosives. Item
> LabCorp ($LH) is rolling out a number of new BRCA diagnostic tests designed to spot patients at risk for breast, ovarian and other cancers. Item
> Biodesix, a molecular diagnostics outfit, raised a $8.3 million Series E preferred equity financing to help boost development, sales and marketing for VeriStrat, a serum protein test that guides therapy for patients with advanced non-small cell lung cancer. Item
> Japan's Sumitomo Heavy Industries said it has obtained the FDA's 510(k) clearance for its proton therapy system, with 12 facilities already operational in the U.S. Item
> Fujifilm won 510(k) clearance for its new Gadolinium and Cesium digital X-ray detectors for pediatric use. Item
Biotech News
@FierceBiotech: PharmAthene scraps Theraclone merger after feds nix funding. More | Follow @FierceBiotech
@JohnCFierce: Forest Labs takes aim at R&D in $500M cost-cutting blitz. News | Follow @JohnCFierce
@DamianFierce: Aptuit poached a former $ICLR VP to serve as next CEO. Story | Follow @DamianFierce
@EmilyMFierce: Novartis announced on Thanksgiving that its scientists have discovered a new malaria target. Release | Follow @EmilyMFierce
> Visterra hires AMAG, Concert vets, licenses dengue antibody from MIT. Story
> FDA delays Biogen's application on hemophilia B therapy. Item
Pharma News
@FiercePharma: Irish plant shutdown puts another Merck site on the block. Story from FiercePharmaManufacturing | Follow @FiercePharma
@EricPFierce: Analysts predicted Forest would do something to cut costs. Here it is. Release | Follow @EricPFierce
@CarlyHFierce: This disease database digitization project is named for Tycho Brahe, Prague's imperial astronomer in the late 1500s. Story | Follow @CarlyHFierce
> KKR bets $200M on India's Gland Pharma. News
> Glaxo CEO Witty visits China in wake of bribery charges. Story
> Japan's Takeda looks to outsider as it reaches for international status. More
Biotech IT News
> Computational biology startup joins Merck KGaA's incubator. More
> Digitization work turns 125 years of disease reports into Big Data goldmine. News
> Pfizer: 'Bring your own device' is coming to clinical trials. Story
> Academics dig into EMRs to discover genetic causes of disease. Article
> Report suggests biopharma wise to outsource cybersecurity. Piece
> Sony files patent for wearable computing 'SmartWig'. Item
CRO News
> Analyst: Pharma R&D cuts won't hamper big CROs. Story
> Almac banks $9M in diagnostics deal with Genomic Health. More
> CRO SillaJen eyes $150M deal for ex-sponsor. News
> Evoke picks SynteractHCR to helm PhIII for diabetes drug. Piece
> Aptuit snags ex-Icon exec to serve as CEO. Article
> Parexel: Strategic partnerships are the future. Item